filmov
tv
Recovery trial: monoclonal antibodies, Martin Landray
Показать описание
Professor Martin Landray describes how monoclonal antibodies are being investigated as a possible treatment for Covid-19 in the Recovery trial.
Oxford Population Health
Рекомендации по теме
0:00:26
Recovery trial: monoclonal antibodies, Martin Landray
0:07:54
RECOVERY Trial - monoclonal antibodies
0:02:42
Introduction to the RECOVERY Trial
0:00:32
Recovery trial: dexamethasone, Martin Landray
0:45:35
'RECOVERY – reflections and future directions' by Professor Sir Martin Landray
0:58:24
RECOVERY trial, one year on
0:01:43
Willis-Knighton enrolling for monoclonal antibody clinical trial
0:00:19
Recovery trial: tocilizumab, Peter Horby
0:05:57
Covid-19: Virus Treatment and Recovery Findings
1:00:29
Hans-Martin Jäck - Prevention and Therapy of COVID-19 with Monoclonal Antibodies
0:02:21
RECOVERY Trial - Participant Information
1:10:36
RECOVERY Trial - Stanford Department of Medicine Grand Rounds-12 August 2020
0:04:18
RECOVERY trial
0:00:23
Recovery trial: azithromycin, Peter Horby
0:02:57
RECOVERY Trial training - High dose corticosteroids
0:33:44
Evidence-based Approach to COVID-19 Treatment and the RECOVERY trial for the Use of Dexamethasone!
0:09:19
Latest Recovery Trial on COVID-19
0:31:24
COVID Conversations: Gavin Screaton on Oxford's response (Live)
0:05:20
The RECOVERY Trial: how to save more than a million lives
0:02:31
UK's COVID-19 Recovery Trial expands to Nepal, Indonesia | Money Talks
0:27:22
Randomised trials in pandemics: essential, not a luxury - April 2022
0:31:23
Convalescent plasma, no benefit
0:52:41
Medical Grand Rounds, September 9, 2021
0:11:51
RECOVERY Trial | Tocilizumab in patients admitted to hospital with COVID-19
0:00:26
0:07:54
0:02:42
0:00:32
0:45:35
0:58:24
0:01:43
0:00:19
0:05:57
1:00:29
0:02:21
1:10:36
0:04:18
0:00:23
0:02:57
0:33:44
0:09:19
0:31:24
0:05:20
0:02:31
0:27:22
0:31:23
0:52:41
0:11:51